Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
983
-
Total 13F shares, excl. options
-
248M
-
Shares change
-
+1.97M
-
Total reported value, excl. options
-
$42.7B
-
Value change
-
+$220M
-
Put/Call ratio
-
1.18
-
Number of buys
-
499
-
Number of sells
-
-528
-
Price
-
$172.26
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q1 2022
1,293 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q1 2022.
Moderna, Inc. - COMMON STOCK (MRNA) has 983 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 248M shares
of 385M outstanding shares and own 64.45% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45.6M shares), BlackRock Inc. (28.7M shares), VANGUARD GROUP INC (27M shares), Flagship Pioneering Inc. (17.6M shares), STATE STREET CORP (14.8M shares), COATUE MANAGEMENT LLC (6.93M shares), GEODE CAPITAL MANAGEMENT, LLC (6.44M shares), Theleme Partners LLP (6.34M shares), RENAISSANCE TECHNOLOGIES LLC (3.82M shares), and NORTHERN TRUST CORP (3.5M shares).
This table shows the top 983 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.